The T box transcription factor TBX2 promotes epithelial-mesenchymal transition and invasion of normal and malignant breast epithelial cells

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Wang, Bin ^a   Lindley, Linsey E ^a   Fernandez Vega, Virneliz ^a,c   Rieger, Megan E ^a,d   Sims, Andrew H ^b   Briegel, Karoline J ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b Edinburgh Cancer Research Centre   (United Kingdom)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TBX2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CANCER CELL; CANCER GROWTH; CANCER RECURRENCE; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL LOSS; CELL MOTILITY; CELL PROLIFERATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; ONCOGENE; PROMOTER REGION; TBX2 GENE;

ANIMALS; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE SILENCING; HUMANS; MAMMARY GLANDS, HUMAN; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; T-BOX DOMAIN PROTEINS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84864228827     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041355     Document Type: Article

References (92)

1. Kelemen LE, Wang X, Fredericksen ZS, Pankratz VS, Pharoah PD, et al. (2009) Genetic variation in the chromosome 17q23 amplicon and breast cancer risk. Cancer Epidemiol Biomarkers Prev 18: 1864-1868.
2. Vance KW, Carreira S, Brosch G, Goding CR, (2005) Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res 65: 2260-2268.
3. Dimova I, Orsetti B, Negre V, Rouge C, Ursule L, et al. (2009) Genomic markers for ovarian cancer at chromosomes 1, 8 and 17 revealed by array CGH analysis. Tumorigenesis 95: 357-366.
4. Liu WK, Jiang XY, Zhang ZX, (2010) Expression of PSCA, PIWIL1, and TBX2 in endometrial adenocarcinoma. Onkologie 33: 241-245.
5. Duo S, Tiao-Dong T, Lei Z, Wei W, Hong-Li S, et al. (2009) Expression and clinical significance of tbx2 in pancreatic cancer. Asian Pac J Cancer Prev 10: 118-122.
6. Barlund M, Monni O, Kononen J, Cornelison R, Torhorst J, et al. (2000) Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res 60: 5340-5344.
7. Sinclair CS, Adem C, Naderi A, Soderberg CL, Johnson M, et al. (2002) TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors. Cancer Res 62: 3587-3591.
8. Andersen CL, Monni O, Wagner U, Kononen J, Barlund M, et al. (2002) High-Throughput Copy Number analysis of 17q23 in 3520 Tissue Specimens by Fluorescence in Situ Hybridization to Tissue Microarrays. Am J Pathol 161: 73-79.
9. Jacobs JJ, Keblusek P, Robanus-Maandag E, Kristel P, Lingbeek M, et al. (2000) Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat Genet 26: 291-299.
10. Redmond KL, Crawford NT, Farmer H, D'Costa ZC, O'Brien GJ, et al. (2010) T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells. Oncogene 29: 3252-3262.
11. Bollag RJ, Siegfried Z, Cebra-Thomas JA, Garvey N, Davison EM, et al. (1994) An Ancient family of embryonically expressed mouse genes sharing a conserved protein motif with the T locus. Nat Genet 7: 383-389.
12. Abrahams A, Parker MI, Prince S, (2010) The T-box transcription factor Tbx2: its role in development and possible implication in cancer. IUBMB Life 62: 92-102.
13. Naiche LA, Harrelson Z, Kelly RG, Papaioannou VE, (2005) T-box genes in vertebrate development. Annu Rev Genet 39: 219-239.
14. Carreira S, Dexter TJ, Yavuzer U, Easty DJ, Goding CR, (1998) Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter. Mol Cell Biol 18: 5099-5108.
15. Lingbeek ME, Jacobs JJ, van Lohuizen M, (2002) The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator. J Biol Chem 277: 26120-26127.
16. Paxton C, Zhao H, Chin Y, Langner K, Reecy J, (2002) Murine Tbx2 contains domains that activate and repress gene transcription. Gene 283: 117-124.
17. Suzuki T, Takeuchi J, Koshiba-Takeuchi K, Ogura T, (2004) Tbx Genes Specify Posterior Digit Identity through Shh and BMP Signaling. Dev Cell 6: 43-53.
18. Harrelson Z, Kelly RG, Goldin SN, Gibson-Brown JJ, Bollag RJ, et al. (2004) Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development. Development 131: 5041-5052.
19. Cho GS, Choi SC, Park EC, Han JK, (2011) Role of Tbx2 in defining the territory of the pronephric nephron. Development 138: 465-474.
20. Fong SH, Emelyanov A, Teh C, Korzh V, (2005) Wnt signalling mediated by Tbx2b regulates cell migration during formation of the neural plate. Development 132: 3587-3596.
21. Manning L, Ohyama K, Saeger B, Hatano O, Wilson SA, et al. (2006) Regional morphogenesis in the hypothalamus: a BMP-Tbx2 pathway coordinates fate and proliferation through Shh downregulation. Dev Cell 11: 873-885.
22. Behesti H, Papaioannou VE, Sowden JC, (2009) Loss of Tbx2 delays optic vesicle invagination leading to small optic cups. Dev Biol 333: 360-372.
23. Chapman DL, Garvey N, Hancock S, Alexiou M, Agulnik SI, et al. (1996) Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development. Dev Dyn 206: 379-390.
24. Jerome-Majewska LA, Jenkins GP, Ernstoff E, Zindy F, Sherr CJ, et al. (2005) Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway. Dev Dyn 234: 922-933.
25. Vance KW, Shaw HM, Rodriguez M, Ott S, Goding CR, (2010) The retinoblastoma protein modulates tbx2 functional specificity. Mol Biol Cell 21: 2770-2779.
26. Martin N, Benhamed M, Nacerddine K, Demarque MD, van Lohuizen M, et al. (2011) Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence. Embo J 31: 95-109.
27. Ribeiro I, Kawakami Y, Buscher D, Raya A, Rodriguez-Leon J, et al. (2007) Tbx2 and Tbx3 regulate the dynamics of cell proliferation during heart remodeling. PLoS One 2: e398.
28. Davis E, Teng H, Bilican B, Parker MI, Liu B, et al. (2008) Ectopic Tbx2 expression results in polyploidy and cisplatin resistance. Oncogene 27: 976-984.
29. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW, (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602.
30. Prince S, Carreira S, Vance KW, Abrahams A, Goding CR, (2004) Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor. Cancer Res 64: 1669-1674.
31. Ismail A, Bateman A, (2009) Expression of TBX2 promotes anchorage-independent growth and survival in the p53-negative SW13 adrenocortical carcinoma. Cancer Lett 278: 230-240.
32. Vormer TL, Foijer F, Wielders CL, te Riele H, (2008) Anchorage-independent growth of pocket protein-deficient murine fibroblasts requires bypass of G2 arrest and can be accomplished by expression of TBX2. Mol Cell Biol 28: 7263-7273.
33. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
34. Hay ED, (2005) The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 233: 706-720.
35. Oft M, Peli J, Rudaz C, Schwarz H, Beug H, et al. (1996) TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 10: 2462-2477.
36. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, et al. (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89.
37. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, et al. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83.
38. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, et al. (2005) DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24: 2375-2385.
39. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, et al. (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7: 1267-1278.
40. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939.
41. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, et al. (2008) Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14: 79-89.
42. Liu Y, El-Naggar S, Darling DS, Higashi Y, Dean DC, (2008) Zeb1 links epithelial-mesenchymal transition and cellular senescence. Development 135: 579-588.
43. Hartwell KA, Muir B, Reinhardt F, Carpenter AE, Sgroi DC, et al. (2006) The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci U S A 103: 18969-18974.
44. Yu M, Smolen GA, Zhang J, Wittner B, Schott BJ, et al. (2009) A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression. Genes Dev 23: 1737-1742.
45. Micalizzi DS, Christensen KL, Jedlicka P, Coletta RD, Baron AE, et al. (2009) The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. J Clin Invest 119: 2678-2690.
46. Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, et al. (2007) Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci U S A.
47. Briegel KJ, (2006) Embryonic transcription factors in human breast cancer. IUBMB Life 58: 123-132.
48. Barrallo-Gimeno A, Nieto MA, (2005) The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132: 3151-3161.
49. Yang J, Weinberg RA, (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829.
50. Vandewalle C, Van Roy F, Berx G, (2009) The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci 66: 773-787.
51. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
52. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, et al. (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3: e2888.
53. Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, et al. (2009) Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A 106: 13820-13825.
54. Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, et al. (2005) The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8: 197-209.
55. Taneja P, Maglic D, Kai F, Zhu S, Kendig RD, et al. (2010) Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance. Clin Med Insights Oncol 4: 15-34.
56. Lindley LE, Briegel KJ, (2010) Molecular characterization of TGFbeta-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells. Biochem Biophys Res Commun 388: 659-664.
57. Sims AH, Smethurst GJ, Hey Y, Okoniewski MJ, Pepper SD, et al. (2008) The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets- improving meta-analysis and prediction of prognosis. BMC Medical Genomics 1: 1-14.
58. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, et al. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100: 8418-8423.
59. Prat A, Parker JS, Karginova O, Fan C, Livasy C, et al. (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12: R68.
60. Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, et al. (2010) Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 107: 15449-15454.
61. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, et al. (2009) Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69: 4116-4124.
62. Turner N, Lambros MB, Horlings HM, Pearson A, Sharpe R, et al. (2010) Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene 29: 2013-2023.
63. Cailleau R, Olive M, Cruciger QV, (1978) Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14: 911-915.
64. Hollestelle A, Nagel JH, Smid M, Lam S, Elstrodt F, et al. (2010) Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res Treat 121: 53-64.
65. Price JE, (1996) Metastasis from human breast cancer cell lines. Breast Cancer Res Treat 39: 93-102.
66. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
67. Christofori G, (2003) Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. Embo J 22: 2318-2323.
68. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, et al. (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-3654.
69. Rodriguez M, Aladowicz E, Lanfrancone L, Goding CR, (2008) Tbx3 represses E-cadherin expression and enhances melanoma invasiveness. Cancer Res 68: 7872-7881.
70. Hajra KM, Ji X, Fearon ER, (1999) Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene 18: 7274-7279.
71. Christoffels VM, Hoogaars WM, Tessari A, Clout DE, Moorman AF, et al. (2004) T-box transcription factor Tbx2 represses differentiation and formation of the cardiac chambers. Dev Dyn 229: 763-770.
72. Shirai M, Imanaka-Yoshida K, Schneider MD, Schwartz RJ, Morisaki T, (2009) T-box 2, a mediator of Bmp-Smad signaling, induced hyaluronan synthase 2 and Tgfbeta2 expression and endocardial cushion formation. Proc Natl Acad Sci U S A 106: 18604-18609.
73. Trujillo KA, Heaphy CM, Mai M, Vargas KM, Jones AC, et al. (2010) Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int J Cancer 129: 1310-1321.
74. Peres J, Davis E, Mowla S, Bennett DC, Li JA, et al. (2011) The Highly Homologous T-Box Transcription Factors, TBX2 and TBX3, Have Distinct Roles in the Oncogenic Process. Genes Cancer 1: 272-282.
75. Brummelkamp TR, Kortlever RM, Lingbeek M, Trettel F, MacDonald ME, et al. (2002) TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence. J Biol Chem 277: 6567-6572.
76. Kumar S, Park SH, Cieply B, Schupp J, Killiam E, et al. (2011) A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition. Mol Cell Biol 31: 4036-4051.
77. Fan W, Huang X, Chen C, Gray J, Huang T, (2004) TBX3 and its isoform TBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines. Cancer Res 64: 5132-5139.
78. Fillmore CM, Gupta PB, Rudnick JA, Caballero S, Keller PJ, et al. (2010) Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc Natl Acad Sci U S A 107: 21737-21742.
79. Lim E, Wu D, Pal B, Bouras T, Asselin-Labat ML, et al. (2010) Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res 12: R21.
80. Bamshad M, Lin RC, Law DJ, Watkins WC, Krakowiak PA, et al. (1997) Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nat Genet 16: 311-315.
81. Davenport TG, Jerome-Majewska LA, Papaioannou VE, (2003) Mammary gland, limb and yolk sac defects in mice lacking Tbx3, the gene mutated in human ulnar mammary syndrome. Development 130: 2263-2273.
82. Chia SK, Speers CH, Bryce CJ, Hayes MM, Olivotto IA, (2004) Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies. J Clin Oncol 22: 1630-1637.
83. Fisher B, Jeong JH, Bryant J, Anderson S, Dignam J, et al. (2004) Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. Lancet 364: 858-868.
84. Ball RK, Friis RR, Schoenenberger CA, Doppler W, Groner B, (1988) Prolactin regulation of b-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J 7: 2089-2095.
85. Chen J, Zhong Q, Wang J, Cameron RS, Borke JL, et al. (2001) Microarray analysis of Tbx2-directed gene expression: a possible role in osteogenesis. Mol Cell Endocrinol 177: 43-54.
86. Rieger ME, Sims AH, Coats ER, Clarke RB, Briegel KJ, (2010) The embryonic transcription cofactor LBH is a direct target of the Wnt signaling pathway in epithelial development and in aggressive basal subtype breast cancers. Mol Cell Biol 30: 4267-4279.
87. Liang CC, Park AY, Guan JL, (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2: 329-333.
88. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, et al. (2004) Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 279: 51630-51646.
89. Camp RL, Dolled-Filhart M, Rimm DL, (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10: 7252-7259.
90. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527.
91. Chin SF, Teschendorff AE, Marioni JC, Wang Y, Barbosa-Morais NL, et al. (2007) High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol 8: R215.
92. Elstrodt F, Hollestelle A, Nagel JH, Gorin M, Wasielewski M, et al. (2006) BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res 66: 41-45.